ALS SOD1 Trial: a ‘Watershed Moment’

Human testing has begun of ISIS-SOD1-Rx, a compound designed to block production of a toxic protein in people with the SOD1-related form of familial (inherited) ALS
This entry was posted in News from Other Sources. Bookmark the permalink. Both comments and trackbacks are currently closed.